1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. GLOBAL DIABETES CARE MARKET BY DEVICES
5.1. Blood Glucose Meters and Strips
5.2. Continuous Glucose Monitors (CGMs)
5.3. Flash Glucose Monitoring Device
5.4. Injection Pens
5.5. Insulin Pumps
5.6. Automated Insulin Delivery Systems
6. GLOBAL DIABETES CARE MARKET BY DRUGS
6.1. Injectable
6.2. Oral
7. GLOBAL DIABETES CARE MARKET BY END-USER
7.1. Hospitals
7.2. Ambulatory Care Units
7.3. Home Care
8. GLOBAL DIABETES CARE MARKET BY GEOGRAPHY
8.1. North America
8.1.1. United States
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. United Kingdom
8.3.2. Germany
8.3.3. France
8.3.4. Italy
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. United Arab Emirates
8.4.3. South Africa
8.4.4. Others
8.5. Asia Pacific
8.5.1. Japan
8.5.2. Korea
8.5.3. China
8.5.4. India
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Recent Deals and Investment
9.2. Strategies of Key Players
9.3. Investment Analysis
10. COMPANY PROFILES
10.1. Roche Products Limited
10.2. Johnson & Johnson Services, Inc.
10.3. Sanofi-Deutschland GmbH
10.4. Novo Nordisk A/S
10.5. Ypsomed AG
10.6. Ascensia Diabetes Care Holdings AG
10.7. Medtronic
10.8. Dexcom, Inc.
10.9. ARKRAY USA, Inc.
10.10. Terumo Europe NV
10.11. Abbott
10.12. BD
10.13. ACON Laboratories, Inc.
LIST OF FIGURES
LIST OF TABLES